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Abstract
Objective—To compare phenotypic and genotypic methods of yeast identification.
Methods—The in-vitro cross-sectional study was conducted from January 2006 to May 2009. 
Invasive yeasts isolated at the clinical microbiology laboratory at the Aga Khan University 
(AKU), Karachi, Pakistan, were identified. Speciation by phenotypic and molecular methods was 
compared. All yeasts isolated during the study period from blood and other invasive sites were 
identified using standard methods. Isolates were shipped to Mycotic Diseases Branch, Centres for 
Disease Control and Prevention, Atlanta, Georgia, USA, for identification by Luminex flow 
cytometric multianalyte profiling (xMAP) system. Ribosomal ITS2 DNA sequencing was 
performed on isolates not identified by Luminex.
Result—Of the 214 invasive yeasts evaluated, Candida species were 209 (97.7%) while the 
frequency of non-Candida species was 5 (2.3%). Overall agreement between phenotypic and 
molecular identification was 81.3%, 90.3% amongst the more common Candida species, and only 
38.8% amongst the uncommon yeasts.
Conclusion—Phenotypic methods of identification proved adequate for common Candida 
species, but were deficient in recognising rare Candida and non-Candida yeasts, highlighting the 
importance of molecular methods for identification.
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Invasive fungal infections are increasingly becoming important infectious agents in this era 
of advancing medical technology.1,2 Invasive yeast infections can cause severe illness with 
high mortality, and with the lowest survival rates seen in cancer patients.3 These infections 
increase the overall cost of management and prolong hospital stay.4 Appropriate and timely 
therapy can significantly reduce mortality.3 Accurate identification of these yeasts is crucial 
for the initiation of appropriate anti-fungal chemotherapy as some species are known to be 
intrinsically resistant to certain anti-fungals.5,6
DNA-based methods are considered authoritative for the identification of fungal isolates.7-9 
The Luminex xMAP (Luminex Corp, Austin, TX USA) is a rapid multiplex system that 
utilises polystyrene beads coupled to oligonucleotide probes directed at the ribosomal ITS2 
regions of major Candida species to detect and differentiate each species in a single 
microtiter well plate by flow cytometry.10 Various forms of this technology have been 
validated as reliable molecular techniques for the identification of various medically 
important fungal species,11 and can be used to speciate Candida isolates as long as their 
specific oligonucleotide probes are available. Although nucleotide sequence analysis is still 
the most accurate molecular method because known species, as well as undescribed species, 
are quickly recognized,12 but the use of the Luminex method with oligonucleotide probes 
for detecting the well-conserved ITS2 region has the advantage of detecting multiple species 
even in mixed cultures if the correct species-specific probes are present.12
However, clinical laboratories in resource-constrained countries like Pakistan have limited 
access to expensive molecular techniques and rely mainly on phenotypic methods for the 
identification of yeasts.13 Phenotypic identification by experienced personnel is effective for 
the identification of most commonly encountered pathogenic yeasts. The identification of 
less frequently encountered species may become problematic or common yeasts may 
manifest strain variation.9 Determining biochemical assimilation profiles of yeasts on API® 
20 C AUX (bioMérieux,SA, Lyon France) alone may be considered the primary phenotypic 
method for yeast identification as it has been reported to have a correct identification rate of 
more than 90% at 72 hours for most clinically relevant species.8,14,15
This study aimed to assess the agreement between conventional phenotypic methods with 
either Luminex xMAP system or DNA sequencing for the identification of invasive yeasts 
isolated from clinical samples in Pakistan.
Materials and Methods
The in-vitro cross-sectional study was conducted between January 2006 and May 2009 at 
the clinical microbiology laboratory, Aga Khan University (AKU), Karachi, Pakistan, and 
the Mycotic Diseases Branch, Centres for Disease Control and Prevention, Atlanta, GA, 
USA. The study included 214 yeasts isolated from 185 patients' sterile sites: 189 from 
blood; 12 from pleural, peritoneal, bile and synovial fluid; 6 from cerebrospinal fluid; and 7 
from the tips of central venous catheters or endoventricular drains. Standard phenotypic 
identification was based on the production of germ tube, inhibition by cycloheximide, urease 
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production, colour and morphology on BiGGY Agar (BD BBL™, USA), microscopic 
morphology on cornmeal-Tween 80 agar and identification profile generated on API 20C 
AUX (bioMérieux, SA, Lyon France) at 72 hours, interpreted according to API 20C 
codebook (1988). Of the supplemental tests suggested by the codebook, bile-esculin test was 
performed for identification of C. lusitaniae. Isolates were saved in glycerol phosphate 
buffer at −80°C, revived and shipped to the Mycotic Diseases Branch, Centers for Disease 
Control and Prevention (CDC), Atlanta, Georgia, USA.
The isolates were then refreshed on Sabouraud dextrose agar to be identified by Luminex 
flow cytometric multianalyte profiling (xMAP) system according to the method of Deak.15 
The principle is based on hybridisation of ribosomal ITS2 region DNA amplicons to 
Candida species-specific oligonucleotide capture probes covalently bound to polystyrene 
beads internally labelled with different ratios of red and infrared dyes so they can be 
distinguished from one another. The target region of interest, in this case the ITS2 region, 
was amplified and concurrently labelled with biotin on the 5′ end of the bead-coupled 
polymerase chain reaction (PCR) amplicon. After hybridisation, the capture probe that binds 
the biotinylated amplicon of the complementary species was then detected by streptavidin-
phycoerythrin (PE) detection buffer which binds to the biotin label. A reporter laser excited 
the PE and a fluorescent signal was detected, processed, and recorded by the multianalyte 
profiling system. The classification laser revealed the unique spectral address of each bead 
(distinguishing one species from another), and the identity laser allowed the system to detect 
specific amplicon binding to the bead. Those isolates which were not identified by the 
Luminex underwent ITS2 gene sequencing for their final identification.16
The study was approved by the Ethical Research Committee of Aga Khan University. SPSS 
version 19.0 was used for data entry and analysis. Male-to-female ratio, mean and standard 
deviation for age of patients was calculated. Agreement of phenotypic and molecular 
methods of yeast identification was calculated using Kappa scores. The following standards 
were used for the strength of agreement for the Kappa coefficient: 0 - 0.0099 as poor; 0.01- 
0.20 as slight; 0.21- 0.40 as fair; 0.41- 0.60 as moderate; 0.61- 0.80 as substantial; and 
0.81-1 as almost perfect.
Results
Out of the total of 185 patients whose samples were taken, the male-to-female ratio was 1.57 
and the mean age was 30.2 ± 26.97 years. The most common species isolated amongst the 
214 invasive yeasts were C.tropicalis (n=69; 32.2%), C.albicans (n=43; 20%), C.parapsilosis 
(n=30; 14.0%), and C.glabrata (n=23; 10.7%), respectively (Table-1). Less common yeasts 
isolated constituted 22.9% (44/214) of the total (Table-2). Five (2.3%) non-Candida isolates 
were identified, four of which were Rhodotorula mucilaginosa from a parenteral nutrition 
outbreak, and one was Cryptococcus neoformans.
Use of phenotypic methods alone showed that correct identification of Candida species, 
making up 97.7% (n=209) of the collection, was found to be inadequate with a Kappa score 
of only 0.13 ± 0.06 compared to DNA-based identification. However, excluding less 
commonly encountered species brought agreement rates up to 0.557±0.07. Phenotypic and 
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molecular identification agreement rates were particularly low for C.guilliermondii, 
C.metapsilosis, C.orthopsilosis, C.viswanathii, C.utilis, C.fabianii and novel Candida species 
and non-Candida isolates, all except 5 C.guilliermondii identified only on DNA-based 
studies. All four R.mucilaginosa isolates were categorised as R.rubra by API 20C AUX. 
Though the identification was low discrimination category (55% R.rubra and 45% 
R.glutinis), it was excellent identification till genus level. However, the supplemental nitrate 
assimilation test, suggested by the API codebook, could not be performed due to the 
unavailability of media. The error thus can be considered minor. One C.neoformans isolate 
was identified correctly by the phenotypic test battery.
Discussion
The epidemiology of invasive yeast infections has globally identified C. albicans as the most 
common species.17 Other prevalent yeasts causing invasive disease are C.tropicalis, 
C.parapsilosis, C.glabrata and C.krusei.17,18 Epidemiology and distribution of invasive 
yeasts show geographical variability, and depend on a variety of risk factors. Most of these 
common Candida species can reliably be identified using phenotypic methods. Thus, yeast 
identification for most surveillance purposes is performed using assimilation tests.19,20 
However, it has been reported before that genotypic identification methods are superior to 
conventional biochemical tests.11,21 In one study, the accuracy of identification has been 
calculated to be 77% for API 20C AUX.21 Our results (81.3%) showed only a minimal 
increase in the efficiency of identification with the addition of microscopic and gross 
morphology, urease and cycloheximide tolerance. Agreement in conventional and genotypic 
identification amongst commonly encountered Candida species was higher than among 
those species less frequently isolated mostly because many of the less frequent species were 
not included in the API codebook. This finding is supported by other studies comparing 
conventional and molecular identification.9,20
The technologist can be faced with the problem of low discriminative identification even 
while using microscopy as a supplementary test.22 This presents difficulty in identifying 
them by conventional methods.20,21 Although such strains are not frequently encountered in 
the clinical laboratory, their mis-identification can have serious consequences on therapeutic 
decisions as several of these rare species may be resistant to fluconazole or amphotericin B, 
the primary drugs used for treating serious fungal infections.9 In cases where definitive 
phenotypic identification is not possible or the microscopic and biochemical features do not 
match, molecular identification can help resolve the conflict.9
Certain yeasts cannot be satisfactorily identified using conventional methods and will 
require molecular identification techniques. These include C.metapsilosis, C.orthopsilosis, 
C.viswanathii, C.fabianii and novel isolates because their profile numbers are not yet 
included in the chemical profile databases.20,23
An important finding highlighting the merits of the Luminex xMAP system is the detection 
of mixed cultures that are missed by conventional methods. Two of our C.albicans isolates, 
both from the same patient, were thought to be pure. When xMAP was performed on the 
isolate, it showed a mixed identification of C.albicans and C.glabrata for both specimens. 
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Hence C.glabrata, a yeast less biochemically active, not forming pseudohyphae and in low 
numbers, was not detected when mixed with C.albicans. This advantage of Luminex xMAP 
system has previously been described by other studies.12,16
With the advent of new molecular diagnostics, several highly efficient and accurate rapid 
methods for identification of micro-organisms are now available, such as Luminex xMAP 
system, matrix-assisted laser desorption ionisation-time of flight (MALDI-TOF) assay, and 
real-time PCRs.16,24,25 What remains to be seen is whether investing in any of these 
advanced techniques will be cost effective for the clinical laboratory.
Conclusion
Conventional identification of yeasts can be considered adequate for identifying species 
commonly encountered in clinical specimens, though it may require more technological 
expertise. Molecular identification methods may be more expensive, but are more accurate. 
Continued surveillance of the spectrum of invasive yeasts can help determine whether it will 
be worthwhile to invest in molecular identification methods in clinical microbiology 
laboratories.
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Table-1
Frequency of invasive yeast species and concordance of phenotypic (API 20C-based) with genotypic 
(Luminex and DNA sequencing) identification methods.
S. No. Species Frequency n (%) Kappa score (S.E.) Mis-identified by phenotypic method as:
1 Candida tropicalis 69 (32.2) 0.946 (0.02) C. glabrata: 2, C. humicola: 1, C. neoformans: 1
2 C. albicans 43 (20.0) 0.956 (0.03) C. rugosa: 1, C. tropicalis: 1
3 C. parapsilosis 30 (14.0) 0.69 (0.06) C.guilliermondii: 1
4 C. glabrata 23 (10.7) 0.670 (0.09) C. humicola: 2, C.parapsilosis: 3, C. albicans: 1, missed: 2
5 C. guilliermondii 13 (6.0) 0.507 (0.14) C. humicola: 1, C. parapsilosis: 5, C. lusitaniae: 1, C. species:
1
6 C. krusei 5 (2.3) 0.887 (0.11) C. lusitaniae: 1
7 C. lusitaniae 4 (1.9) 0.721 (0.15) -
8 C. metapsilosis 4 (1.9) -* All C. parapsilosis
9 C. orthopsilosis 4 (1.9) -* C. parapsilosis: 3, C. lusitaniae: 1
10 C. viswanathii 4 (1.9) -* C. parapsilosis: 3, C. lusitaniae: 1
11 Rhodotorula mucilaginosa 4 (1.9) -* All as R. rubra
12 C. pelliculosa 3 (1.4) 1.00 (0.00) -
13 C. utilis 2 (0.9) -* Both as C. species
14 C. kefyr 1 (0.5) 1.00 (0.00) -
15 C. rugosa 1 (0.5) 0.665 (0.31) -
16 C. fabianii 1 (0.5) -* C. species
17 Novel Candida spp. MCR C. haemulonii 1 (0.5) -* C. species
18 Novel Candida spp. 1 (0.5) -* C. parapsilosis
19 Cryptococcus neoformans 1 (0.5) 0.665 (0.31) -
Total 214 (100) - -
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Table-2
Molecular and phenotypic identification agreement rates amongst yeast groups.
Species (n) Percentage of 214 invasive yeasts studied (n) Kappa score (S.E.)
Common Candida spp.* 77.1% (170) 0.557 (0.07)
Uncommon yeasts 22.9% (44) 0.237 (0.05)
All Candida species 97.7% (209) 0.13 (0.06)
All non-Candida species 2.3% (5) 0.036 (0.02)
C. glabrata isolates not detected on phenotypic identification 0.9% (2) -
*
Common Candida species include C.tropicalis, C.albicans, C.parapsilosis and C.glabrata.
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